Truist lowered the firm’s price target on Accolade to $7.50 from $9 and keeps a Buy rating on the shares. The firm is adjusting its model to reflect the company’s Q2 earnings, affirmed FY25 guidance, and the management’s views on the selling season, the analyst tells investors in a research note.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACCD: